Preferred Label : quinoxalines;

MeSH synonym : Quinoxaline;

Wikipedia link : https://en.wikipedia.org/wiki/Quinoxalines;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3280978/fr/maviret-vhc-pediatrique
2021
false
false
false
France
glecaprevir and pibrentasvir
administration, oral
insurance, health, reimbursement
treatment outcome
child
hepatitis C, chronic
antiviral agents
evaluation of the transparency committee
glecaprevir
pibrentasvir
benzimidazoles
glecaprevir and pibrentasvir
drug combinations
pyrrolidines
quinoxalines
sulfonamides

---
https://www.has-sante.fr/jcms/p_3224398/fr/maviret
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
glecaprevir and pibrentasvir
Glecaprevir/Pibrentasvir
glecaprevir
pibrentasvir
antiviral agents
insurance, health, reimbursement
Duration of treatment (qualifier value)
hepatitis C, chronic
glecaprevir
benzimidazoles
quinoxalines
sulfonamides
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
https://www.has-sante.fr/jcms/p_3114479/fr/maviret
2019
false
false
false
France
French
insurance, health, reimbursement
treatment outcome
antiviral agents
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
glecaprevir
pibrentasvir
administration, oral
glecaprevir and pibrentasvir
hepatitis C, chronic
adult
adolescent
renal insufficiency, chronic
Duration of treatment (qualifier value)
glecaprevir
quinoxalines
sulfonamides
benzimidazoles
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
https://www.has-sante.fr/jcms/p_3114485/fr/maviret
2019
false
false
false
France
glecaprevir and pibrentasvir
adult
adolescent
hepatitis C, chronic
glecaprevir
pibrentasvir
antiviral agents
insurance, health, reimbursement
treatment outcome
administration, oral
evaluation of the transparency committee
glecaprevir
quinoxalines
sulfonamides
benzimidazoles
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds

---
Maviret - glecaprevir / pibrentasvir
https://www.ema.europa.eu/medicines/human/EPAR/Maviret
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
treatment outcome
product surveillance, postmarketing
drug combinations
antiviral agents
antiviral agents
tablets
administration, oral
hepatitis C, chronic
adult
drug interactions
pregnancy
breast feeding
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)
Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)
drug evaluation, preclinical
glecaprevir and pibrentasvir
benzimidazoles
benzimidazoles
glecaprevir
glecaprevir
pibrentasvir
pibrentasvir
glecaprevir
glecaprevir
quinoxalines
sulfonamides
quinoxalines
sulfonamides
glecaprevir and pibrentasvir
pyrrolidines

---
https://www.has-sante.fr/portail/jcms/c_2818016/fr/maviret
https://www.has-sante.fr/portail/jcms/c_2818016/fr/maviret-glecaprevir-/pibrentasvir-association-fixe-d-antiviraux-a-action-directe
2017
false
false
false
false
French
treatment outcome
drug combinations
antiviral agents
antiviral agents
administration, oral
hepatitis C, chronic
adult
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)
Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)
glecaprevir and pibrentasvir
evaluation of the transparency committee
insurance, health, reimbursement
glecaprevir
glecaprevir
benzimidazoles
benzimidazoles
guidelines for drug use
pibrentasvir
pibrentasvir
glecaprevir
glecaprevir
quinoxalines
sulfonamides
quinoxalines
sulfonamides
glecaprevir and pibrentasvir
pyrrolidines

---
https://www.ema.europa.eu/medicines/human/EPAR/Zepatier
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
elbasvir
elbasvir
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
adult
hepatitis C, chronic
antiviral agents
viral vaccines
Hepatitis C virus subtype 1a (organism)
Hepatitis C virus subtype 1b (organism)
Hepatitis C virus genotype 4 (organism)
administration, oral
drug antagonism
drug evaluation, preclinical
NS-5a protein, hepatitis C virus
protease inhibitors
protease inhibitors
NS3 protein, hepatitis C virus
NS4A cofactor peptide, hepatitis C virus
drug therapy, combination
elbasvir-grazoprevir drug combination
elbasvir and grazoprevir
NS-5 protein, hepatitis C virus
quinoxalines
quinoxalines
benzofurans
imidazoles
viral nonstructural proteins
carrier proteins
benzofurans
imidazoles
benzofurans
imidazoles
quinoxalines

---
http://www.prescrire.org/Fr/3/31/49345/0/2014/ArchiveNewsDetails.aspx?page=1
2014
false
false
false
french abstract
smoking cessation
benzazepines
quinoxalines

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/882
2012
false
false
false
Canada
Cardiotoxicity
journal article
acute coronary syndrome
benzazepines
quinoxalines

---
https://medicalforum.ch/fr/detail/doi/fms.2009.06970/
2009
false
true
false
Switzerland
journal article
tobacco use cessation
benzazepines
quinoxalines

---
Nous contacter.
04/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.